全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

T淋巴细胞在肿瘤中的研究进展
Research Progress of T Lymphocyte in Tumor

DOI: 10.12677/acm.2024.1441385, PP. 3012-3020

Keywords: T淋巴细胞,肿瘤免疫微环境,CD4 T淋巴细胞,CD8 T淋巴细胞,进展
T Lymphocytes
, Tumor Immune Microenvironment, CD4 T Lymphocytes, CD8 T Lymphocytes, Progression

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:介绍T淋巴细胞在肿瘤微环境中所发挥的免疫调节作用的研究现状。方法:查阅并总结国内外近年来有关肿瘤微环境中T淋巴细胞发生发展及预后相关性的基础和临床应用研究的相关文献并加以综述。结果:肿瘤微环境中T淋巴细胞具有明显的复杂性和多样性,免疫抑制环境的抑制性免疫细胞和发挥抗肿瘤作用的刺激性免疫细胞共同促进或抑制了癌症的发生和进展。结论:T淋巴细胞在肿瘤微环境中的确切作用仍有待进一步研究。随着相关的研究成果不断积累,更多的肿瘤患者将从免疫治疗中获益。
Objective: To introduce the research status of T lymphocytes in immunoregulatory role in tumor microenvironment. Methods: The basic and clinical studies on T lymphocyte development and prognosis in tumor microenvironment were reviewed. Results: There were obvious complexity and diversity of T lymphocytes in the tumor microenvironment. The inhibitory immune cells in the immunosuppressive environment and the stimulating immune cells in the anti-tumor environment jointly promoted or inhibited the occurrence and progression of cancer. Conclusion: The exact role of T lymphocytes in the tumor microenvironment remains to be further studied. With the accumulation of relevant research results, more cancer patients will benefit from immunotherapy.

References

[1]  Notarbartolo, S. and Abrignani, S. (2022) Human T Lymphocytes at Tumor Sites. Seminars in Immunopathology, 44, 883-901.
https://doi.org/10.1007/s00281-022-00970-4
[2]  Shih, H., Sciumè, G., Poholek, A.C., et al. (2014) Transcriptional and Epigenetic Networks of Helper T and Innate Lymphoid Cells. Immunological Reviews, 261, 23-49.
https://doi.org/10.1111/imr.12208
[3]  Wan, Y.Y. and Flavell, R.A. (2009) How Diverse-CD4 Effector T Cells and Their Functions. Journal of Molecular Cell Biology, 1, 20-36.
https://doi.org/10.1093/jmcb/mjp001
[4]  Basu, A., Ramamoorthi, G., Albert, G., et al. (2021) Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy. Frontiers in Immunology, 12, Article 669474.
https://doi.org/10.3389/fimmu.2021.669474
[5]  Poncette, L., Bluhm, J. and Blankenstein, T. (2022) The Role of CD4 T Cells in Rejection of Solid Tumors. Current Opinion in Immunology, 74, 18-24.
https://doi.org/10.1016/j.coi.2021.09.005
[6]  Kim, H.-J. and Cantor, H. (2014) CD4 T-Cell Subsets and Tumor Immunity: The Helpful and the Not-So-Helpful. Cancer Immunology Research, 2, 91-98.
https://doi.org/10.1158/2326-6066.CIR-13-0216
[7]  Xie, Q., Ding, J. and Chen, Y. (2021) Role of CD8 T Lymphocyte Cells: Interplay with Stromal Cells in Tumor Microenvironment. Acta Pharmaceutica Sinica B, 11, 1365-1378.
https://doi.org/10.1016/j.apsb.2021.03.027
[8]  Ohshima, K. and Morii, E. (2021) Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis. Metabolites, 11, Article 28.
https://doi.org/10.3390/metabo11010028
[9]  Noer, J.B., Talman, M.-L.M. and Moreira, J.M.A. (2021) HLA Class II Histocompatibility Antigen γ Chain (CD74) Expression Is Associated with Immune Cell Infiltration and Favorable Outcome in Breast Cancer. Cancers, 13, Article 6179.
https://doi.org/10.3390/cancers13246179
[10]  Koyama, S. and Nishikawa, H. (2021) Mechanisms of Regulatory T Cell Infiltration in Tumors: Implications for Innovative Immune Precision Therapies. Journal for ImmunoTherapy of Cancer, 9, e002591.
https://doi.org/10.1136/jitc-2021-002591
[11]  Hariyanto, A.D., Permata, T.B.M. and Gondhowiardjo, S.A. (2022) Role of CD4 CD25 FOXP3 T Reg Cells on Tumor Immunity. Immunological Medicine, 45, 94-107.
https://doi.org/10.1080/25785826.2021.1975228
[12]  Tay, R.E., Richardson, E.K. and Toh, H.C. (2021) Revisiting the Role of CD4 T Cells in Cancer Immunotherapy—New Insights into Old Paradigms. Cancer Gene Therapy, 28, 5-17.
https://doi.org/10.1038/s41417-020-0183-x
[13]  Busselaar, J., Tian, S., Van Eenennaam, H., et al. (2020) Helpless Priming Sends CD8 T Cells on the Road to Exhaustion. Frontiers in Immunology, 11, Article 592569.
https://doi.org/10.3389/fimmu.2020.592569
[14]  Quezada, S.A., Simpson, T.R., Peggs, K.S., et al. (2010) Tumor-Reactive CD4 T Cells Develop Cytotoxic Activity and Eradicate Large Established Melanoma after Transfer into Lymphopenic Hosts. Journal of Experimental Medicine, 207, 637-650.
https://doi.org/10.1084/jem.20091918
[15]  Xie, Y., Akpinarli, A., Maris, C., et al. (2010) Naive Tumor-Specific CD4 T Cells Differentiated in vivo Eradicate Established Melanoma. Journal of Experimental Medicine, 207, 651-667.
https://doi.org/10.1084/jem.20091921
[16]  Perez-Diez, A., Joncker, N.T., Choi, K., et al. (2007) CD4 Cells Can be More Ef?cient at Tumor Rejection than CD8 Cells. Blood, 109, 5346-5354.
https://doi.org/10.1182/blood-2006-10-051318
[17]  McCaw, T.R., Li, M., Starenki, D., et al. (2019) The Expression of MHC Class II Molecules on Murine Breast Tumors Delays T-Cell Exhaustion, Expands the T-Cell Repertoire, and Slows Tumor Growth. Cancer Immunology, Immunotherapy, 68, 175-188.
https://doi.org/10.1007/s00262-018-2262-5
[18]  McLane, L.M., Abdel-Hakeem, M.S. and Wherry, E.J. (2019) CD8 T Cell Exhaustion during Chronic Viral Infection and Cancer. Annual Review of Immunology, 37, 457-495.
https://doi.org/10.1146/annurev-immunol-041015-055318
[19]  Oh, D.Y., Kwek, S.S., Raju, S.S., et al. (2020) Intratumoral CD4 T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer. Cell, 181, 1612-1625. E13.
https://doi.org/10.1016/j.cell.2020.05.017
[20]  Woroniecka, K.I., Rhodin, K.E., Dechant, C., et al. (2020) 4-1BB Agonism Averts TIL Exhaustion and Licenses PD-1 Blockade in Glioblastoma and Other Intracranial Cancers. Clinical Cancer Research, 26, 1349-1358.
https://doi.org/10.1158/1078-0432.CCR-19-1068
[21]  Woroniecka, K., Chongsathidkiet, P., Rhodin, K., et al. (2018) T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma. Clinical Cancer Research, 24, 4175-4186.
https://doi.org/10.1158/1078-0432.CCR-17-1846
[22]  Alspach, E., Lussier, D.M., Miceli, A.P., et al. (2019) MHC-II Neoantigens Shape Tumour Immunity and Response to Immunotherapy. Nature, 574, 696-701.
https://doi.org/10.1038/s41586-019-1671-8
[23]  Ahrends, T., Spanjaard, A., Pilzecker, B., et al. (2017) CD4 T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness. Immunity, 47, 848-861.
https://doi.org/10.1016/j.immuni.2017.10.009
[24]  Wu, T., Zhang, X., Liu, X., et al. (2023) Single-Cell Sequencing Reveals the Immune Microenvironment Landscape Related to Anti-PD-1 Resistance in Metastatic Colorectal Cancer with High Microsatellite Instability. BMC Medicine, 21, Article No. 161.
https://doi.org/10.1186/s12916-023-02866-y
[25]  Damei, I., Trickovic, T., Mami-Chouaib, F., et al. (2023) Tumor-Resident Memory T Cells as a Biomarker of the Response to Cancer Immunotherapy. Frontiers in Immunology, 14, Article 1205984.
https://doi.org/10.3389/fimmu.2023.1205984
[26]  Brummel, K., Eerkens, A.L., De Bruyn, M., et al. (2023) Tumour-Infiltrating Lymphocytes: From Prognosis to Treatment Selection. British Journal of Cancer, 128, 451-458.
https://doi.org/10.1038/s41416-022-02119-4
[27]  Pizzolla, A., Keam, S.P., Vergara, I.A., et al. (2022) Tissue-Resident Memory T Cells from a Metastatic Vaginal Melanoma Patient Are Tumor-Responsive T Cells and Increase after Anti-PD-1 Treatment. Journal for ImmunoTherapy of Cancer, 10, e004574.
https://doi.org/10.1136/jitc-2022-004574
[28]  Corgnac, S., Malenica, I., Mezquita, L., et al. (2020) CD103 CD8 TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17. Cell Reports Medicine, 1, Article 100127.
https://doi.org/10.1016/j.xcrm.2020.100127
[29]  Baba, Y., Nomoto, D., Okadome, K., et al. (2020) Tumor Immune Microenvironment and Immune Checkpoint Inhibitors in Esophageal Squamous Cell Carcinoma. Cancer Science, 111, 3132-3141.
https://doi.org/10.1111/cas.14541
[30]  Lin, R., Zhang, H., Yuan, Y., et al. (2020) Fatty Acid Oxidation Controls CD8 Tissue-Resident Memory T-cell Survival in Gastric Adenocarcinoma. Cancer Immunology Research, 8, 479-492.
https://doi.org/10.1158/2326-6066.CIR-19-0702
[31]  Lim, C.J., Lee, Y.H., Pan, L., et al. (2019) Multidimensional Analyses Reveal Distinct Immune Microenvironment in Hepatitis B Virus-Related Hepatocellular Carcinoma. Gut, 68, 916-927.
https://doi.org/10.1136/gutjnl-2018-316510
[32]  Laumont, C.M., Wouters, M.C.A., Smazynski, J., et al. (2021) Single-Cell Profiles and Prognostic Impact of Tumor-Infiltrating Lymphocytes Coexpressing CD39, CD103, and PD-1 in Ovarian Cancer. Clinical Cancer Research, 27, 4089-4100.
https://doi.org/10.1158/1078-0432.CCR-20-4394
[33]  Martinez-Usatorre, A., Carmona, S.J., Godfroid, C., et al. (2020) Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells. Frontiers in Immunology, 11, Article 340.
https://doi.org/10.3389/fimmu.2020.00340
[34]  Schauder, D.M., Shen, J., Chen, Y., et al. (2021) E2A-Regulated Epigenetic Landscape Promotes Memory CD8 T Cell Differentiation. Proceedings of the National Academy of Sciences, 118, e2013452118.
https://doi.org/10.1073/pnas.2013452118
[35]  Booth, J.S. and Toapanta, F.R. (2021) B and T Cell Immunity in Tissues and Across the Ages. Vaccines, 9, Article 24.
https://doi.org/10.3390/vaccines9010024
[36]  Gauthier, T. and Chen, W. (2022) Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections. Frontiers in Immunology, 13, Article 780839.
https://doi.org/10.3389/fimmu.2022.780839
[37]  Zhao, S., Peralta, R.M., Avina-Ochoa, N., et al. (2021) Metabolic Regulation of T Cells in the Tumor Microenvironment by Nutrient Availability and Diet. Seminars in Immunology, 52, Article 101485.
https://doi.org/10.1016/j.smim.2021.101485
[38]  Nguyen, K.B. and Spranger, S. (2020) Modulation of the Immune Microenvironment by Tumor-Intrinsic Oncogenic Signaling. Journal of Cell Biology, 219, e201908224.
https://doi.org/10.1083/jcb.201908224
[39]  Safarzadeh, E. (2021) STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells from Breast Cancer Patients. Frontiers in Immunology, 11, Article 613215.
https://doi.org/10.3389/fimmu.2020.613215
[40]  Mao, X., Xu, J., Wang, W., et al. (2021) Crosstalk between Cancer-Associated Fibroblasts and Immune Cells in the Tumor Microenvironment: New Findings and Future Perspectives. Molecular Cancer, 20, Article No. 131.
https://doi.org/10.1186/s12943-021-01428-1
[41]  Dzobo, K. (2020) Cancer-Associated Fibroblasts: Origins, Heterogeneity and Functions in Tumor Microenvironment. OMICS, Preprint.
https://doi.org/10.20944/preprints202001.0155.v1
[42]  Ginefra, P., Lorusso, G. and Vannini, N. (2020) Innate Immune Cells and Their Contribution to T-Cell-Based Immunotherapy. International Journal of Molecular Sciences, 21, Article 4441.
https://doi.org/10.3390/ijms21124441
[43]  Zadka, ?. Grybowski, D.J. and Dzi?giel, P. (2020) Modeling of the Immune Response in the Pathogenesis of Solid Tumors and Its Prognostic Significance. Cellular Oncology, 43, 539-575.
https://doi.org/10.1007/s13402-020-00519-3
[44]  Abolhassani, H., Wang, Y., Hammarstr?m, L., et al. (2021) Hallmarks of Cancers: Primary Antibody Deficiency versus Other Inborn Errors of Immunity. Frontiers in Immunology, 12, Article 720025.
https://doi.org/10.3389/fimmu.2021.720025
[45]  Zuo, B., Kuai, J., Long, J., Bian, J., Yang, X., Yang, X., Xun, Z., Li, Y., Sun, H., Sang, X. and Zhao, H. (2022) Differentially Expressed Liver Exosome-Related Genes as Candidate Prognostic Biomarkers for Hepatocellular Carcinoma. Annals of Translational Medicine, 10, 817.
https://doi.org/10.21037/atm-21-4400
[46]  Zhou, P., Chen, L., Yan, D., et al. (2020) Early Variations in Lymphocytes and T Lymphocyte Subsets Are Associated with Radiation Pneumonitis in Lung Cancer Patients and Experimental Mice Received Thoracic Irradiation. Cancer Medicine, 9, 3437-3444.
https://doi.org/10.1002/cam4.2987
https://pubmed.ncbi.nlm.nih.gov/32207253/
[47]  Zhang, J.-J., Zhao, R., Xia, F., et al. (2022) Cost-Effectiveness Analysis of rhTPO and rhIL-11 in the Treatment of Chemotherapy-Induced Thrombocytopenia in Hematological Tumors Based on Real-World Data. Annals of Palliative Medicine, 11, 2709-2719.
https://doi.org/10.21037/apm-22-880
[48]  Vahidi, Y., Bagheri, M., Ghaderi, A., et al. (2020) CD8-Positive Memory T Cells in Tumor-Draining Lymph Nodes of Patients with Breast Cancer. BMC Cancer, 20, Article No. 257.
https://doi.org/10.1186/s12885-020-6714-x
[49]  Gentric, G. and Mechta-Grigoriou, F. (2021) Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective. Cancers, 13, Article 399.
https://doi.org/10.3390/cancers13030399

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133